BerGenBio ASA (OSL: BGBIO)
Norway
· Delayed Price · Currency is NOK 10.90
-0.18 (-1.62%)
Aug 30, 2024, 4:25 PM CET
BerGenBio ASA Balance Sheet
Financials in millions NOK. Fiscal year is January - December.
Millions NOK. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '24 Jun 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2014 |
| Cash & Equivalents | 200.12 | 156.42 | 150.8 | 436.65 | 721.64 | 253.59 | Upgrade
|
| Cash & Short-Term Investments | 200.12 | 156.42 | 150.8 | 436.65 | 721.64 | 253.59 | Upgrade
|
| Cash Growth | -11.44% | 3.73% | -65.46% | -39.49% | 184.57% | -29.64% | Upgrade
|
| Other Receivables | 12.87 | 10.09 | 14.06 | 11.7 | 13.5 | 15.45 | Upgrade
|
| Receivables | 12.87 | 10.09 | 14.06 | 11.7 | 13.5 | 15.45 | Upgrade
|
| Prepaid Expenses | 5.26 | 7.39 | 1.8 | 0.7 | 0.73 | 0.37 | Upgrade
|
| Other Current Assets | - | 0 | - | 0 | - | - | Upgrade
|
| Total Current Assets | 218.25 | 173.9 | 166.66 | 449.05 | 735.87 | 269.4 | Upgrade
|
| Property, Plant & Equipment | 0.22 | 0.43 | 0.04 | 1.19 | 2.33 | 0.97 | Upgrade
|
| Other Long-Term Assets | -0 | - | - | - | -0 | - | Upgrade
|
| Total Assets | 218.47 | 174.34 | 166.71 | 450.24 | 738.2 | 270.38 | Upgrade
|
| Accounts Payable | 8.62 | 18.61 | 29.63 | 26.73 | 22.55 | 26.75 | Upgrade
|
| Accrued Expenses | - | 27.79 | 48.3 | 37.46 | 43.4 | 23.29 | Upgrade
|
| Current Portion of Leases | - | 0.42 | - | 0.68 | 0.65 | 0.59 | Upgrade
|
| Other Current Liabilities | 34.58 | 0.04 | - | 0 | - | 0 | Upgrade
|
| Total Current Liabilities | 43.21 | 46.86 | 77.93 | 64.87 | 66.6 | 50.62 | Upgrade
|
| Long-Term Debt | - | - | 0.28 | - | 1.37 | - | Upgrade
|
| Long-Term Leases | - | - | - | 0.94 | - | - | Upgrade
|
| Total Liabilities | 43.21 | 46.86 | 78.21 | 65.81 | 67.97 | 50.62 | Upgrade
|
| Common Stock | 39.09 | 268.87 | 8.87 | 8.85 | 8.73 | 6.11 | Upgrade
|
| Additional Paid-In Capital | 8.79 | 0.85 | 35.78 | 335.2 | 628.23 | 187.79 | Upgrade
|
| Retained Earnings | 76.93 | -189.23 | - | - | - | - | Upgrade
|
| Comprensive Income & Other | 50.46 | 46.99 | 43.85 | 40.39 | 33.27 | 25.86 | Upgrade
|
| Shareholders' Equity | 175.26 | 127.48 | 88.5 | 384.43 | 670.23 | 219.75 | Upgrade
|
| Total Liabilities & Equity | 218.47 | 174.34 | 166.71 | 450.24 | 738.2 | 270.38 | Upgrade
|
| Total Debt | - | 0.42 | 0.28 | 1.62 | 2.02 | 0.59 | Upgrade
|
| Net Cash (Debt) | 200.12 | 156 | 150.53 | 435.02 | 719.62 | 253 | Upgrade
|
| Net Cash Growth | -11.44% | 3.64% | -65.40% | -39.55% | 184.44% | -29.80% | Upgrade
|
| Net Cash Per Share | 6.91 | 10.90 | 169.83 | 494.59 | 960.53 | 435.98 | Upgrade
|
| Filing Date Shares Outstanding | 39.09 | 26.89 | 0.89 | 0.88 | 0.87 | 0.61 | Upgrade
|
| Total Common Shares Outstanding | 39.09 | 26.89 | 0.89 | 0.88 | 0.87 | 0.61 | Upgrade
|
| Working Capital | 175.04 | 127.05 | 88.73 | 384.18 | 669.27 | 218.78 | Upgrade
|
| Book Value Per Share | 4.48 | 4.74 | 99.82 | 434.60 | 768.08 | 359.80 | Upgrade
|
| Tangible Book Value | 175.26 | 127.48 | 88.5 | 384.43 | 670.23 | 219.75 | Upgrade
|
| Tangible Book Value Per Share | 4.48 | 4.74 | 99.82 | 434.60 | 768.08 | 359.80 | Upgrade
|
| Machinery | - | 1.73 | 1.73 | 1.77 | 1.77 | 1.7 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.